* 1. Should patients with CKD stage 3-5 (non-dialysis) and hyperphosphatemia receive non-calcium containing binders only?

* 2. Should patients with hypertension who are on dialysis preferentially receive ACE inhibitors/ARBs (as opposed to beta blockers)?

* 3. Should statin medications be discontinued in patients with CKD 5D who are age 75 years and older?

Tell us about yourself:

* 4. Professional status:

* 5. Years in practice:

* 6. Practice location: